Abstract:BACKGROUND:Human myelogenous leukemia characterized by either the non random t(8; 21)(q22; q22) or t(16; 21)(q24; q22) chromosome translocations differ for both their biological and clinical features. Some of these features could be consequent to differential epigenetic transcriptional deregulation at AML1 targets imposed by AML1-MTG8 and AML1-MTG16, the fusion proteins deriving from the two translocations. Preliminary findings showing that these fusion proteins lead to transcriptional downregulation of AML1 targets, marked by repressive chromatin changes, would support this hypothesis. Here we show that combining conventional global gene expression arrays with the power of bioinformatic genomic survey of AML1-consensus sequences is an effective strategy to identify AML1 targets whose transcription is epigenetically downregulated by the leukemia-associated AML1-MTG16 protein. RESULTS:We interrogated mouse gene expression microarrays with probes generated either from 32D cells infected with a retroviral vector carrying AML1-MTG16 and unable of granulocyte differentiation and proliferation in response to the granulocyte colony stimulating factor (G-CSF), or from 32D cells infected with the cognate empty vector. From the analysis of differential gene expression alone (using as criteria a p value < 0.01 and an absolute fold change > 3), we were unable to conclude which of the 37 genes downregulated by AML1-MTG16 were, or not, direct AML1 targets. However, when we applied a bioinformatic approach to search for AML1-consensus sequences in the 10 Kb around the gene transcription start sites, we closed on 17 potential direct AML1 targets. By focusing on the most significantly downregulated genes, we found that both the AML1-consensus and the transcription start site chromatin regions were significantly marked by aberrant repressive histone tail changes. Further, the promoter of one of these genes, containing a CpG island, was aberrantly methylated. CONCLUSION:This study shows that a leukemia-associated fusion protein can impose a distinct epigenetic repressive signature at specific sites in the genome. These findings strengthen the conclusion that leukemia-specific oncoproteins can induce non-random epigenetic changes.

New Insight of Leukemic Stem Cell

Re-Evaluation of Various Molecular Targets Located on Cd34(+)Cd38(-)Lin(-) Leukemia Stem Cells and Other Cell Subsets in Pediatric Acute Myeloid Leukemia

N-Cadherin and Tie2 Positive CD34+CD38−CD123+ Leukemic Stem Cell Populations Can Develop Acute Myeloid Leukemia More Effectively in NOD/SCID Mice

A Distinct Epigenetic Signature at Targets of a Leukemia Protein

Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ Leukemic Stem Cells by Chemotherapy-Resistance.

Leukemia Stem Cells: the Root of Chronic Myeloid Leukemia

Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia

Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications

The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting

C-Mpl is a Candidate Surface Marker and Confers Self-Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells

Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties

Biology and relevance of human acute myeloid leukemia stem cells.

Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth

Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease

Chemoresistant Leukemia-Initiating Cell Expansion is Inhibited by Targeting Oncogenic Self-Renewal

Recent progress on targeting leukemia stem cells

CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia

The epigenetic state of the cell of origin defines mechanisms of leukemogenesis

Determination of Leukemia Stem Cells in Childhood Acute Myeloid Leukemia and Its Clinical Significance

3185 – THE HEMATOPOIETIC ECOSYSTEM IN ACUTE MYELOID LEUKEMIA